Migraine Disorders

"Migraine Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Descriptor ID	D008881
MeSH Number(s)	C10.228.140.546.399.750
Concept/Terms	Migraine Disorders Migraine Disorders Disorder, Migraine Disorders, Migraine Migraine Disorder Migraine Migraines Migraine Headache Headache, Migraine Headaches, Migraine Migraine Headaches Acute Confusional Migraine Acute Confusional Migraine Acute Confusional Migraines Migraine, Acute Confusional Migraines, Acute Confusional Status Migrainosus Status Migrainosus Hemicrania Migraine Hemicrania Migraine Hemicrania Migraines Migraine, Hemicrania Migraines, Hemicrania Migraine Variant Migraine Variant Migraine Variants Variant, Migraine Variants, Migraine Sick Headache Sick Headache Headache, Sick Headaches, Sick Sick Headaches Abdominal Migraine Abdominal Migraine Abdominal Migraines Migraine, Abdominal Migraines, Abdominal Cervical Migraine Syndrome Cervical Migraine Syndrome Cervical Migraine Syndromes Migraine Syndrome, Cervical Migraine Syndromes, Cervical

Below are MeSH descriptors whose meaning is more general than "Migraine Disorders".

Diseases [C]
Nervous System Diseases [C10]
Central Nervous System Diseases [C10.228]
Brain Diseases [C10.228.140]
Headache Disorders [C10.228.140.546]
Headache Disorders, Primary [C10.228.140.546.399]
Migraine Disorders [C10.228.140.546.399.750]

Below are MeSH descriptors whose meaning is related to "Migraine Disorders".

Below are MeSH descriptors whose meaning is more specific than "Migraine Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Migraine Disorders" by people in this website by year, and whether "Migraine Disorders" was a major or minor topic of these publications.

Bar chart showing 481 publications over 23 distinct years, with a maximum of 33 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	24	1	25
2003	22	2	24
2004	29	1	30
2005	25	1	26
2006	24	3	27
2007	29	1	30
2008	30	3	33
2009	28	4	32
2010	22	2	24
2011	13	2	15
2012	14	1	15
2013	12	1	13
2014	12	0	12
2015	12	3	15
2016	13	0	13
2017	11	1	12
2018	27	0	27
2019	18	0	18
2020	9	1	10
2021	19	0	19
2022	20	0	20
2023	17	0	17
2024	23	1	24

Below are the most recent publications written about "Migraine Disorders" by people in Profiles.

Tepper SJ, Diamond ML, Hirman J, Asher D, Fiore D, Cady R. Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures. J Neurol. 2024 Dec 12; 272(1):4.

View in: PubMed
Peterlin BL, Bond DS, Ailani J, Dodick DW, Liu Y, De Abreu Ferreira R, Smith JH, Dabruzzo B, Goadsby PJ, Trugman JM. Weight loss with atogepant during the preventive treatment of migraine: A pooled analysis. Cephalalgia. 2024 Dec; 44(12):3331024241299753.

View in: PubMed
Kopruszinski CM, Lee G, Martin LK, Barber KR, Moutal A, Dodick DW, Navratilova E, Porreca F. A male-specific mechanism of meningeal nociceptor sensitization promoting migraine headache. Cephalalgia. 2024 Sep; 44(9):3331024241281493.

View in: PubMed
Puledda F, Sacco S, Diener HC, Ashina M, Al-Khazali HM, Ashina S, Burstein R, Liebler E, Cipriani A, Chu MK, Cocores A, Dodd-Glover F, Ekizoglu E, Garcia-Azorin D, G?bel CH, Goicochea MT, Hassan A, Hirata K, Hoffmann J, Jenkins B, Kamm K, Lee MJ, Ling YH, Lisicki M, Martinelli D, Monteith TS, Ornello R, ?zge A, Peres MFP, Pozo-Rosich P, Romanenko V, Schwedt TJ, Souza MNP, Takizawa T, Terwindt GM, Thuraiaiyah J, Togha M, Vandenbussche N, Wang SJ, Yu S, Tassorelli C. International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine. Cephalalgia. 2024 Sep; 44(9):3331024241269735.

View in: PubMed
Lipton RB, Harriott AM, Ma JY, Smith JH, Stokes J, Gandhi P, Jariwala-Parikh K, Jensen GS, Trugman JM, Dodick DW. Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial. Neurology. 2024 Sep 24; 103(6):e209745.

View in: PubMed
Pozo-Rosich P, Alpuente A, Silberstein SD, Burstein R. Insights from 25?years of onabotulinumtoxinA in migraine - mechanisms and management. Nat Rev Neurol. 2024 09; 20(9):555-568.

View in: PubMed
Charleston L. Developing and delivering a migraine disparities and diagnosis undergraduate medical educational program to underrepresented in medicine medical student members of the Student National Medical Association: A pilot project. Headache. 2024 09; 64(8):967-972.

View in: PubMed
Robblee J, Orlova YY, Ahn AH, Ali AS, Birlea M, Charleston L, Singh NN, Souza MNP. Real-world approaches to outpatient treatment of status migrainosus: A survey study. Headache. 2024 09; 64(8):1040-1048.

View in: PubMed
Silberstein SD, Diener HC, Dodick DW, Sommer K, Lipton RB. Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials. Headache. 2024 Jul-Aug; 64(7):838-848.

View in: PubMed
Al-Khazali HM, Christensen RH, Dodick DW, Chaudhry BA, Melchior AG, Burstein R, Ashina H. Hypersensitivity to BKCa channel opening in persistent post-traumatic headache. J Headache Pain. 2024 Jun 18; 25(1):102.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement